Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide

被引:52
作者
Viriyakosol, S
Mathison, JC
Tobias, PS
Kirkland, TN
机构
[1] Univ Calif San Diego, Sch Med, Vet Affairs San Diego Healthcare Syst, Dept Pathol,Infect Dis Sect, San Diego, CA 92161 USA
[2] Univ Calif San Diego, Sch Med, Vet Affairs San Diego Healthcare Syst, Dept Med, San Diego, CA 92161 USA
[3] Scripps Res Inst, La Jolla, CA 92037 USA
关键词
D O I
10.1074/jbc.275.5.3144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD14 is a glycophosphatidylinositol-linked protein expressed by myeloid cells and also circulates as a plasma protein lacking the glycophosphatidylinositol anchor. Both membrane and soluble CD14 function to enhance activation of cells by lipopolysaccharide (LPS), which we refer to as receptor function. We have previously reported the LPS binding and cell activation functions of a group of five deletion mutants of CD14 (Viriyakosol, S., and Kirkland, T.N. (1995) J. Biol. Chem. 270, 361-368). We have now studied the functional impact of these mutations on soluble CD14. We found that some deletions that abrogated LPS binding in membrane CD14 have no effect on LPS binding in soluble CD14. In fact, some of the soluble CD14 deletion mutants bound LPS with an apparent higher affinity than wild-type CD14. Furthermore, we found that all five deletions essentially ablated soluble CD14 LPS receptor function, whereas only two of the deletions completely destroyed membrane CD14 LPS receptor function. Some of the mutants were able to compete with wild-type CD14 in soluble CD14-dependent assays of cellular activation. We concluded that the soluble and membrane forms of CD14 have different structural determinants for LPS receptor function.
引用
收藏
页码:3144 / 3149
页数:6
相关论文
共 36 条
[1]   THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469
[2]  
DESCH CE, 1989, LYMPHOKINE RES, V8, P141
[3]   Human CD14 mediates recognition and phagocytosis of apoptotic cells [J].
Devitt, A ;
Moffatt, OD ;
Raykundalia, C ;
Capra, JD ;
Simmons, DL ;
Gregory, CD .
NATURE, 1998, 392 (6675) :505-509
[4]   Binding of bacterial peptidoglycan to CD14 [J].
Dziarski, R ;
Tapping, RI ;
Tobias, PS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8680-8690
[5]   THE INVOLVEMENT OF CD14 IN STIMULATION OF CYTOKINE PRODUCTION BY URONIC-ACID POLYMERS [J].
ESPEVIK, T ;
OTTERLEI, M ;
SKJAKBRAEK, G ;
RYAN, L ;
WRIGHT, SD ;
SUNDAN, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (01) :255-261
[6]   SOLUBLE CD14 PARTICIPATES IN THE RESPONSE OF CELLS TO LIPOPOLYSACCHARIDE [J].
FREY, EA ;
MILLER, DS ;
JAHR, TG ;
SUNDAN, A ;
BAZIL, V ;
ESPEVIK, T ;
FINLAY, BB ;
WRIGHT, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1665-1671
[7]   CD14 is a cell-activating receptor for bacterial peptidoglycan [J].
Gupta, D ;
Kirkland, TN ;
Viriyakosol, S ;
Dziarski, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (38) :23310-23316
[8]  
HAZIOT A, 1988, J IMMUNOL, V141, P547
[9]   Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice [J].
Haziot, A ;
Ferrero, E ;
Kontgen, F ;
Hijiya, N ;
Yamamoto, S ;
Silver, J ;
Stewart, CL ;
Goyert, SM .
IMMUNITY, 1996, 4 (04) :407-414
[10]   Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts [J].
Hogan, LH ;
Josvai, S ;
Klein, BS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30725-30732